Red Clover

Vincamine is a semi-synthetic derivative, extracted using a proprietary methodto Linnea, vetted to GMP-standard quality controls, obtaining a state-of-theartproduct. Vincamine is CEP certified, and complies with Ph.Eur. monograph“Vincamine”, that Linnea developed.

Linnea’s Vinpocetine is a semi-synthetic derivative, extracted using a provenmethod, vetted with in-house GMP-standard quality controls, resulting in ahigh-quality profile and outstanding therapeutic value end product. Linnea’sVinpocetine is compliant with the European Pharmacopoeia and is CEP certified.

Linnea’s Vinpocetine is a semi-synthetic derivative, extracted using a provenmethod, vetted with in-house GMP-standard quality controls, resulting in ahigh-quality profile and outstanding therapeutic value end product. Linnea’sVinpocetine is compliant with the European Pharmacopoeia and is CEP certified.

A treasure trove of active ingredients just waiting to be rediscovered. Linnea’s therapeutic Cannabinoid solutions are the culmination of more than four decades of experience and unrivaled attention to quality. Linnea' CBD is compliant with the new Ph. Eur. Monograph.

5-hydroxytryptophan is an amino-acid with nootropic and antidepressant actions,naturally present in the brain and found in food in small doses. Exogenous therapeutic 5 HTP is isolated from the seeds of the African plant Griffonia simplicifolia.

Grown in forests in Northern Europe, our antioxidant-rich bilberries are transformed into GMP certified and approved dry extracts. 

Linnea’s Ginkgo Biloba dry extract is derived in two different methods, allowing to obtain two different products, Ginkgo Biloba EPG 246, and Ginkgo Biloba Ethanol,suitable for pharmaceutical and food applications respectively, with comparable activity. Linnea's Ginkgo Biloba complies with the current edit...

HMRlignan® is extracted from the Picea abies L. (Norway Spruce) plant.The raw material is harvested in a sustainable way, working with local forestry commissions and authorities. Linnea has a special extraction method and its HMRlignan® has a unique activity as a result.

The European Directorate for the Quality of Medicines & Healthcare (EDQM) has issued a CEP certificate for our Vincamine product, making Linnea the first company in the world to have a CEP-certified Vincamine extract.

Sustainability is a company-wide priority:we partner with local farmers in the Swiss canton of Ticino converting organic waste into energy thanks to a biogas plant, and we voluntarily adhere to the Swiss Private Sector Energy Agency Program, for a minimal CO2 footprint.

Linnea is proud to comply with the new CBD monograph issued by the European Pharmacopoeia. This monograph is applicable for medical prescriptions, pharmacy compounding, clinical trials, pharmaceutical development, and registrations.

LINNEA’S GINKGO BILOBA BOTANICAL EXTRACT IS AN EFFECTIVE ACTIVE INGREDIENT THAT EMBODIES THE COMPANY PHILOSOPHY AND COMMITMENT TO QUALITY WHILE BENEFITING BOTH BODY AND MIND.

BY CLOSELY MONITORING THE ENTIRE PRODUCTION CHAIN, LINNEAENSURES UNIFORMITY AND RELIABILITY ACROSS ALL BATCHES OF ITS REDCLOVER EXTRACT, COMPOSED OF A PRECISE RATIO OF FOUR DIFFERENT ISOFLAVONES (FORMONONETIN, BIOCHAIN A, GENISTEIN AND DAIDZEIN).

OUR HMRLIGNAN™ IS A CONCENTRATED WELLSPRING OF HEALTH, PROVIDING EXPONENTIALLY MORE LIGNANS COMPARED TO DIETARY SOURCES.

A snapshot of Linnea, its mission, vision, commitment to the environment and product sheets of the full Linnea API portfolio.